Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jinbuhuan Gutong is a Traditional Chinese Medicine (TCM) topical formulation, typically presented as a medicated patch or plaster, developed by Guilin Tianhe Pharmaceuticals. It is specifically indicated for the treatment of knee osteoarthritis, bone hyperplasia, and associated joint pain or stiffness. The formulation is centered around the herbal extract Jinbuhuan (derived from *Lycopodium serratum* or *Stephania* species), which contains active alkaloids such as L-tetrahydropalmatine (L-THP). These constituents provide analgesic and anti-inflammatory effects by modulating neurotransmitter receptors and local inflammatory mediators. The patch is designed for transdermal delivery, allowing the herbal active ingredients to penetrate the skin and reach the affected joint tissues to promote blood circulation, reduce swelling, and alleviate chronic pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jinbuhuan Gutong.